CalciMedica, Inc. (CALC)
1.15
0.00 (0.00%)
USD |
NASDAQ |
Oct 22, 16:00
1.22
+0.07
(+6.09%)
After-Hours: 20:00
CalciMedica Enterprise Value : -2.348M for Oct. 22, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 22, 2026 | -2.348M |
| October 21, 2026 | -2.348M |
| October 20, 2026 | -2.870M |
| October 19, 2026 | -3.147M |
| October 16, 2026 | -3.024M |
| October 15, 2026 | -2.778M |
| October 14, 2026 | -2.839M |
| October 13, 2026 | -2.532M |
| October 12, 2026 | -2.010M |
| October 09, 2026 | -1.610M |
| October 08, 2026 | -1.426M |
| October 07, 2026 | -0.319M |
| October 06, 2026 | -0.2575M |
| October 05, 2026 | 0.0498M |
| October 02, 2026 | 0.4187M |
| October 01, 2026 | 0.726M |
| September 30, 2026 | 0.5416M |
| September 29, 2026 | 0.4802M |
| September 28, 2026 | 0.9105M |
| September 25, 2026 | 1.341M |
| September 24, 2026 | 1.279M |
| September 23, 2026 | 1.587M |
| September 22, 2026 | 2.078M |
| September 21, 2026 | 2.017M |
| September 18, 2026 | 2.386M |
| Date | Value |
|---|---|
| September 17, 2026 | 2.693M |
| September 16, 2026 | 2.755M |
| September 15, 2026 | 2.755M |
| September 14, 2026 | 2.878M |
| September 11, 2026 | 2.755M |
| September 10, 2026 | 3.615M |
| September 09, 2026 | 4.691M |
| September 08, 2026 | 3.000M |
| September 04, 2026 | 3.923M |
| September 03, 2026 | 4.107M |
| September 02, 2026 | 3.492M |
| September 01, 2026 | 2.878M |
| August 31, 2026 | 3.738M |
| August 28, 2026 | 4.857M |
| August 27, 2026 | 5.029M |
| August 26, 2026 | 8.641M |
| August 25, 2026 | 8.656M |
| August 24, 2026 | 7.685M |
| August 21, 2026 | 8.189M |
| August 20, 2026 | 8.508M |
| August 19, 2026 | 9.428M |
| August 18, 2026 | 10.19M |
| August 17, 2026 | 10.95M |
| August 14, 2026 | 11.33M |
| August 13, 2026 | 10.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.929B |
| Corcept Therapeutics, Inc. | 11.30B |
| Veru, Inc. | 15.94M |
| Johnson & Johnson | 671.59B |
| Eli Lilly & Co. | 1.276T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.652M |
| Total Expenses (Quarterly) | 7.652M |
| EPS Diluted (Quarterly) | -2.237 |
| Earnings Yield | -590.2% |
| Normalized Earnings Yield | -564.78 |